XML 20 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)
Preferred Stock [Member]
Series B Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Stock [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Dec. 31, 2013 0 7,612,838          
Balance at Dec. 31, 2013 $ 0 $ 761 $ 5,409,103 $ (5,282,875) $ (100,000) $ (147,581) $ (120,592)
Foreign currency translation (loss)           (1,070) (1,070)
Stock compensation - stock options     477,868       477,868
Net Loss     (1,023,422)     (1,023,422)
Balance (in shares) at Dec. 31, 2015 0 7,612,838          
Balance at Dec. 31, 2015 $ 0 $ 761 5,886,971 (6,306,297) (100,000) (148,651) (667,216)
Foreign currency translation (loss)           (32,984) (32,984)
Stock compensation - stock options     546,134       546,134
Net Loss       (2,275,826)     (2,275,826)
Atrinsic shares converted (in shares) 297,468 25,867          
Atrinsic shares converted $ 1 $ 3 63,381       63,385
Protagenic shares converted (in shares) 6,612,838 (7,612,838)          
Protagenic shares converted $ 6 $ (761) (99,245)   $ 100,000    
Private offerings, net of expenses (in shares) 4,108,460            
Private offerings, net of expenses $ 4 4,761,793       4,761,797
Conversion of series B Preferred Stock (in shares) (10,146,000) 60,211          
Conversion of series B Preferred Stock $ (10) $ 829 (819)        
Conversion of Bridge loan   $ 6 75,259       $ 75,265
Stock options converted to common (in shares)   25,000         25,000
Stock options converted to common   $ 2 6,498       $ 6,500
Balance (in shares) at Dec. 31, 2016 872,766 10,257,078          
Balance at Dec. 31, 2016 $ 1 $ 840 $ 11,239,972 $ (8,582,123)   $ (181,635) $ 2,477,055